You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 6, June 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Neoplasms
 •Prognosis/ Outcomes
 •Alert me on articles by topic

The Role of Microsatellites as a Prognostic Factor in Primary Malignant Melanoma

Ladan Shaikh, MD; Richard W. Sagebiel, MD; Carlos M. M. Ferreira, MD; Mehdi Nosrati, BS; James R. Miller III, PhD; Mohammed Kashani-Sabet, MD

Arch Dermatol. 2005;141:739-742.

Objective  To determine the impact of microsatellites as a prognostic factor in primary cutaneous melanoma.

Design  Retrospective cohort study.

Setting  Tertiary referral center.

Patients  A total of 504 patients with a history of primary melanoma observed for 2 years or having experienced a first relapse.

Main Outcome Measures  Overall survival (OS) and relapse-free survival (RFS).

Results  Forty-five patients had evidence of microsatellites in their primary melanoma. Presence of microsatellites significantly correlated with the presence of several other histologic high-risk factors such as tumor thickness, ulceration, Clark level, vascular factors, and mitotic rate. Univariate analysis demonstrated decreased RFS and OS in patients with microsatellites. Presence of microsatellites was associated with increased locoregional metastasis but not distant metastasis. In multivariate analysis, with the inclusion of 6 other clinical and histologic factors, presence of microsatellites was a significant predictor of RFS but not OS. Patients with clinical macrosatellites had a trend toward worsening OS compared with those with microsatellites.

Conclusions  The presence of microsatellites is intimately tied to other markers of melanoma aggressiveness. Microsatellites appear to predict locoregional relapse and RFS but neither distant metastasis nor OS. These results may have implications for patient care as well as the inclusion of microsatellites in stage III of the current classification.


Author Affiliations: Melanoma Center, Cutaneous Oncology Program, Cancer Center, University of California, San Francisco.


RELATED LETTERS

A Seeming Failure of Logic
A. Bernard Ackerman
Arch Dermatol. 2006;142(2):244-245.
EXTRACT | FULL TEXT  

A Seeming Failure of Logic—Reply
Mohammed Kashani-Sabet and Richard W. Sagebiel
Arch Dermatol. 2006;142(2):245.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Excision Margins for Primary Cutaneous Melanoma Invited Critique
Balch et al.
Arch Surg 2007;142:891-893.
FULL TEXT  

Case 2-2007 -- A 49-Year-Old Woman with a Pigmented Lesion on the Arm
Thompson et al.
NEJM 2007;356:285-292.
FULL TEXT  

A seeming failure of logic.
Ackerman
Arch Dermatol 2006;142:244-245.
FULL TEXT  

A Seeming Failure of Logic--Reply
Kashani-Sabet and Sagebiel
Arch Dermatol 2006;142:245-245.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.